• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生命体征:2018 年美国结直肠癌筛查检测使用情况。

Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018.

机构信息

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.

出版信息

MMWR Morb Mortal Wkly Rep. 2020 Mar 13;69(10):253-259. doi: 10.15585/mmwr.mm6910a1.

DOI:10.15585/mmwr.mm6910a1
PMID:32163384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7075255/
Abstract

BACKGROUND

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States of cancers that affect both men and women. Despite strong evidence that screening for CRC reduces incidence and mortality, CRC screening prevalence is below the national target. This report describes current CRC screening prevalence by age, various demographic factors, and state.

METHODS

Data from the 2018 Behavioral Risk Factor Surveillance System survey were analyzed to estimate the percentages of adults aged 50-75 years who reported CRC screening consistent with the United States Preventive Services Task Force recommendation.

RESULTS

In 2018, 68.8% of adults were up to date with CRC screening. The percentage up to date was 79.2% among respondents aged 65-75 years and 63.3% among those aged 50-64 years. CRC screening prevalence was lowest among persons aged 50-54 years (50.0%) and increased with age. Among respondents aged 50-64 years, CRC screening prevalence was lowest among persons without health insurance (32.6%) and highest among those with reported annual household income of ≥$75,000 (70.8%). Among respondents aged 65-75 years, CRC screening prevalence was lowest among those without a regular health care provider (45.6%), and highest among those with reported annual household income ≥$75,000 (87.1%). Among states, CRC screening prevalence was highest in Massachusetts (76.5%) and lowest in Wyoming (57.8%).

DISCUSSION

CRC screening prevalence is lower among adults aged 50-64 years, although most reported having a health care provider and health insurance. Concerted efforts are needed to inform persons aged <50 years about the benefit of screening so that screening can start at age 50 years.

摘要

背景

结直肠癌(CRC)是美国男女共患的癌症死亡的第二大原因。尽管有强有力的证据表明 CRC 筛查可降低发病率和死亡率,但 CRC 筛查的普及率低于国家目标。本报告描述了按年龄、各种人口统计学因素和州划分的当前 CRC 筛查普及率。

方法

对 2018 年行为风险因素监测系统调查的数据进行了分析,以估计报告符合美国预防服务工作组建议的 50-75 岁成年人中 CRC 筛查的百分比。

结果

2018 年,有 68.8%的成年人接受了 CRC 筛查。65-75 岁的受访者中有 79.2%接受了筛查,而 50-64 岁的受访者中有 63.3%接受了筛查。CRC 筛查的普及率在 50-54 岁人群中最低(50.0%),并随年龄增长而增加。在 50-64 岁的受访者中,无健康保险的人 CRC 筛查的普及率最低(32.6%),而报告年收入≥75000 美元的人 CRC 筛查的普及率最高(70.8%)。在 65-75 岁的受访者中,无常规医疗保健提供者的人 CRC 筛查的普及率最低(45.6%),而报告年收入≥75000 美元的人 CRC 筛查的普及率最高(87.1%)。在各州中,马萨诸塞州的 CRC 筛查普及率最高(76.5%),怀俄明州最低(57.8%)。

讨论

尽管大多数人报告有医疗服务提供者和健康保险,但 50-64 岁的成年人 CRC 筛查的普及率较低。需要做出协调一致的努力,使年龄<50 岁的人了解筛查的益处,以便从 50 岁开始进行筛查。

相似文献

1
Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018.生命体征:2018 年美国结直肠癌筛查检测使用情况。
MMWR Morb Mortal Wkly Rep. 2020 Mar 13;69(10):253-259. doi: 10.15585/mmwr.mm6910a1.
2
Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.生命体征:50-75 岁成年人的结直肠癌筛查-美国,2008 年。
MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):808-12.
3
Vital signs: colorectal cancer screening test use--United States, 2012.生命体征:2012 年美国结直肠癌筛查检测使用情况。
MMWR Morb Mortal Wkly Rep. 2013 Nov 8;62(44):881-8.
4
Factors Associated with Colorectal Cancer Screening among Mississippi Adults: Findings from the Behavioral Risk Factor Surveillance System.密西西比州成年人结直肠癌筛查相关因素:行为风险因素监测系统的结果。
South Med J. 2020 Jul;113(7):360-365. doi: 10.14423/SMJ.0000000000001115.
5
Colorectal Cancer Screening in US Seniors Ages 76-84 Years.美国76 - 84岁老年人的结直肠癌筛查
J Community Health. 2015 Aug;40(4):769-79. doi: 10.1007/s10900-015-9998-z.
6
Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind.结直肠癌筛查在高危人群中日益增多,尽管目前吸烟者有所滞后。
Cancer. 2014 Jul 15;120(14):2106-13. doi: 10.1002/cncr.28707. Epub 2014 Apr 15.
7
Differences in colorectal cancer screening rates across income strata by levels of urbanization: results from the Canadian Community Health Survey (2013/2014).按城市化水平划分的不同收入阶层的结直肠癌筛查率差异:来自加拿大社区健康调查(2013/2014 年)的结果。
Can J Public Health. 2019 Feb;110(1):62-71. doi: 10.17269/s41997-018-0143-5. Epub 2018 Oct 23.
8
How many individuals will need to be screened to increase colorectal cancer screening prevalence to 80% by 2018?要使 2018 年结直肠癌筛查普及率提高到 80%,需要对多少人进行筛查?
Cancer. 2015 Dec 1;121(23):4258-65. doi: 10.1002/cncr.29659. Epub 2015 Aug 26.
9
Cigarette smoking and cancer screening underutilization by state: BRFSS 2010.各州人群中吸烟和癌症筛查未充分利用的情况:BRFSS 2010。
Nicotine Tob Res. 2014 Sep;16(9):1183-9. doi: 10.1093/ntr/ntu047. Epub 2014 Apr 2.
10
Vital signs: breast cancer screening among women aged 50-74 years - United States, 2008.生命体征:50-74 岁女性的乳腺癌筛查 - 美国,2008 年。
MMWR Morb Mortal Wkly Rep. 2010 Jul 9;59(26):813-6.

引用本文的文献

1
Does First-Time Colon Cancer Screening Beyond Age 75 Reduce Cancer Risk Without Significant Complications? Insights From a Large US Retrospective Study.75岁以上首次进行结肠癌筛查能否降低癌症风险且无重大并发症?来自美国一项大型回顾性研究的见解。
Cancer Med. 2025 Sep;14(17):e71200. doi: 10.1002/cam4.71200.
2
Development and Validation of an Automated, Real-time Adenoma Detection Rate and Colonoscopy Quality Metrics Calculator.自动化实时腺瘤检出率及结肠镜检查质量指标计算器的开发与验证
Tech Innov Gastrointest Endosc. 2024;26(1):2-11. doi: 10.1016/j.tige.2023.07.004. Epub 2023 Jul 28.
3
Sustainability of evidence based interventions implemented in CDC's colorectal cancer control program.

本文引用的文献

1
Initiation of Colorectal Cancer Screening Among Medicaid Enrollees.启动医疗补助计划参保者的结直肠癌筛查。
Am J Prev Med. 2020 Feb;58(2):224-231. doi: 10.1016/j.amepre.2019.09.015. Epub 2019 Nov 28.
2
Patients' self-reported barriers to colon cancer screening in federally qualified health center settings.联邦合格医疗中心环境下患者自我报告的结肠癌筛查障碍。
Prev Med Rep. 2019 May 15;15:100896. doi: 10.1016/j.pmedr.2019.100896. eCollection 2019 Sep.
3
Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.
疾病控制与预防中心(CDC)结直肠癌控制项目中实施的循证干预措施的可持续性。
Implement Sci Commun. 2025 Jul 9;6(1):73. doi: 10.1186/s43058-025-00734-9.
4
Persistent Poverty, Rural Location, and Racial Segregation Are Factors in Colorectal Cancer Screening in Low-Income and Uninsured Populations.长期贫困、农村地区居住以及种族隔离是低收入和未参保人群结直肠癌筛查的影响因素。
J Adv Pract Oncol. 2025 May 4:1-13. doi: 10.6004/jadpro.2025.16.7.14.
5
Health Policy and Screening for Colorectal Cancer in the United States.美国的卫生政策与结直肠癌筛查
Cancers (Basel). 2025 Jun 16;17(12):2003. doi: 10.3390/cancers17122003.
6
Detection of Early-Stage Colorectal Cancer Using Cell-Free oncRNA Biomarkers and Artificial Intelligence.使用无细胞癌源性RNA生物标志物和人工智能检测早期结直肠癌
Clin Cancer Res. 2025 Aug 1;31(15):3229-3238. doi: 10.1158/1078-0432.CCR-25-0449.
7
Cancer screening and its associated factors in hypertensive individuals: new insights from the 2021 STEPs national study in Iran.高血压患者的癌症筛查及其相关因素:2021年伊朗全国STEP研究的新见解
BMC Public Health. 2025 Apr 18;25(1):1454. doi: 10.1186/s12889-025-22423-x.
8
Optimal Approach to Colorectal Cancer Screening.结直肠癌筛查的最佳方法。
Gastroenterol Hepatol (N Y). 2025 Mar;21(3):163-171.
9
A Blood-Based Assay for Detection of Patients with Advanced Adenomas.一种用于检测晚期腺瘤患者的血液检测方法。
Cancer Res Commun. 2025 Apr 1;5(4):621-631. doi: 10.1158/2767-9764.CRC-24-0398.
10
Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA.美国COVID-19大流行前后结直肠癌筛查实际依从性的纵向回顾性研究。
BMJ Public Health. 2025 Mar 13;3(1):e001734. doi: 10.1136/bmjph-2024-001734. eCollection 2025 Jan.
影响年度粪便免疫化学试验用于结直肠癌的实用临床试验依从性的因素。
J Gen Intern Med. 2019 Jun;34(6):978-985. doi: 10.1007/s11606-018-4820-0. Epub 2019 Jan 25.
4
Patterns and Trends in Cancer Screening in the United States.美国癌症筛查的模式和趋势。
Prev Chronic Dis. 2018 Jul 26;15:E97. doi: 10.5888/pcd15.170465.
5
Barriers to Colorectal Cancer Screening in a Racially Diverse Population Served by a Safety-Net Clinic.安全网诊所服务的种族多样化人群中结直肠癌筛查的障碍
J Community Health. 2017 Aug;42(4):791-796. doi: 10.1007/s10900-017-0319-6.
6
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.结直肠癌筛查策略的益处、负担及危害评估:美国预防服务工作组的建模研究
JAMA. 2016 Jun 21;315(23):2595-609. doi: 10.1001/jama.2016.6828.
7
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
8
Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.人口健康推广时代初级保健就诊与结直肠癌筛查结果之间的关联
J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8.
9
Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening.评估参与结直肠癌筛查的促进因素和障碍的定性研究的系统评价与荟萃综合分析
Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):907-17. doi: 10.1158/1055-9965.EPI-15-0990. Epub 2016 Apr 13.
10
Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018.到2018年在美国实现80%的结直肠癌筛查率对公共卫生的影响。
Cancer. 2015 Jul 1;121(13):2281-5. doi: 10.1002/cncr.29336. Epub 2015 Mar 12.